| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer | Director +1 more
2 companies
Grant Pickering is Chief Executive Officer at PCVX and has filed Form 4s across 2 companies. From December 2020 to September 2026, the filings on record show 1 open-market purchase and 57 sales. Grant Pickering's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $26.2M at current prices.
Historically, Grant Pickering's trades have earned a middling insider score of 50/100 across 63 rated trades. Over a 12-month horizon, 38.3% of those trades were profitable, with an average 12-month return of -21.8%.
The biggest single holding is PCVX (~$26.1M) as Chief Executive Officer. The PCVX filings lean toward selling, a net 740,510 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 2,616 | $73.70 | $192,799.23 | -1.7% | -2.1% | +1.8% | |
| Feb 26, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 45,000 | $78.09 | $3,514,106.06 | -10.7% | -13.0% | +0.5% | |
| Jan 29, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 30,000 | $66.03 | $1,980,900.00 | -7.4% | -10.9% | +34.5% | |
| Jan 23, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $63.92 | $958,782.94 | -3.8% | -5.4% | +33.1% | |
| Jan 2, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 2,616 | $63.89 | $167,144.19 | -1.7% | +6.0% | +32.3% | |
| Dec 26, 2023 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $61.70 | $925,537.70 | -3.8% | +6.5% | +37.7% | |
| Dec 1, 2023 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 2,618 | $52.12 | $136,442.39 | -1.7% | +37.2% | +75.3% | |
| Nov 24, 2023 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 15,000 | $49.09 | $736,299.73 | -3.9% | +49.7% | +79.5% | |
| Nov 1, 2023 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 2,618 | $47.29 | $123,812.69 | -1.7% | +40.3% | +121.6% | |
| Oct 23, 2023 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 15,000 | $47.07 | $706,070.15 | -3.7% | +34.9% | +140.2% |